Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

The Evolving Regulatory Paradigm of AI in MedTech: A Review of Perspectives and Where We Are Today.

PMID: 38528278 ·

K, a, r, e, n, , Z, h, o, u, ;, , G, i, n, n, y, , G, a, t, t, i, n, g, e, r

RevistaTherapeutic innovation & regulatory science
Año
PMID38528278

Resumen

Artificial intelligence (AI)-enabled technologies in the MedTech sector hold the promise to transform healthcare delivery by improving access, quality, and outcomes. As the regulatory contours of these technologies are being defined, there is a notable lack of literature on the key stakeholders such as the organizations and interest groups that have a significant input in shaping the regulatory framework. This article explores the perspectives and contributions of these stakeholders in shaping t

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑